Respiratory interaction studies in rodents, ability of a test article to reverse the respiratory depressant effects of opioids. TO5. Period of performance: march 21, 2024 - march 20, 2025.
Ended Awarded Last action
- Contract number
- 75N95024F00002
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $211,128
Award facts
- Opportunity
-
- 75N95024F00001 Solicitation number
- Contract value 100% obligated
- $211,128.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $211,128 |
About this award
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The $211,128.00 contract is for respiratory interaction studies in rodents to assess the ability of a test article to reverse the respiratory depressant effects of opioids. The work supports NIDA's mission to advance potential treatments for drug-induced respiratory depression and overdose toxicity. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute has held multiple federal contracts and grants with NIH, the Department of Defense, and the Biomedical Advanced Research and Development Authority to provide animal modeling, preclinical development, and related research services across the drug development lifecycle.
Quick answers
Who was awarded contract 75N95024F00002?
75N95024F00002 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on March 21, 2024.
How much is contract 75N95024F00002 worth?
The government has obligated $211,128 on 75N95024F00002.
Is contract 75N95024F00002 an order under another contract?
Yes. 75N95024F00002 is a delivery order under 75N95022D00019, an indefinite delivery contract.
Was contract 75N95024F00002 competed?
The extent of competition for 75N95024F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award